Adial Pharmaceuticals' Seed VC Round

Adial Pharmaceuticals raised a round of funding on November 05, 2013. Investors include Cato BioVentures.

Adial Pharmaceuticals is focused on developing effective medications to treat addiction and related disorders. The company's most advanced compound AD04 specifically targets Alcohol Use Disorder throu…

Articles about Adial Pharmaceuticals' Seed VC Round: